Peripheral Vascular Devices Market to Grow
Analysis based on 8 articles · First reported Mar 03, 2026 · Last updated Mar 18, 2026
The peripheral vascular devices market is projected to grow significantly, driven by increasing prevalence of vascular diseases and advancements in minimally invasive procedures. This growth presents a positive outlook for medical device manufacturers like Boston Scientific and Medtronic, particularly in North America.
The global peripheral vascular devices market is experiencing steady expansion, projected to reach USD 13.22 billion by 2031 with a CAGR of 5.7% from 2026. This growth is primarily fueled by the rising incidence of peripheral artery disease, deep vein thrombosis, and other vascular disorders, which are linked to an aging global population, diabetes, obesity, and smoking. The increasing adoption of minimally invasive endovascular procedures, such as angioplasty, stenting, atherectomy, and thrombectomy, is also a key driver due to shorter recovery times and improved clinical outcomes. Technological advancements in drug-coated balloons, advanced stent technologies, and intravascular imaging further enhance treatment effectiveness. Emerging markets like Asia-Pacific, Latin America, and the Middle East & Africa are becoming significant growth hubs due to improving healthcare infrastructure and rising disease prevalence. North America currently holds the largest market share, supported by advanced healthcare infrastructure and favorable reimbursement policies. Key companies in this market, including Boston Scientific, Medtronic, and Abbott Laboratories, are focusing on product innovation and strategic partnerships to strengthen their positions.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard